387 related articles for article (PubMed ID: 17965883)
1. A review of clinical and molecular prognostic factors in osteosarcoma.
Clark JC; Dass CR; Choong PF
J Cancer Res Clin Oncol; 2008 Mar; 134(3):281-97. PubMed ID: 17965883
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
5. An update on chemotherapy for osteosarcoma.
Ferrari S; Serra M
Expert Opin Pharmacother; 2015; 16(18):2727-36. PubMed ID: 26512909
[TBL] [Abstract][Full Text] [Related]
6. Periosteal osteosarcoma--a European review of outcome.
Grimer RJ; Bielack S; Flege S; Cannon SR; Foleras G; Andreeff I; Sokolov T; Taminiau A; Dominkus M; San-Julian M; Kollender Y; Gosheger G;
Eur J Cancer; 2005 Dec; 41(18):2806-11. PubMed ID: 16290134
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors affecting prognosis of limb osteosarcoma in China: a multicenter retrospective analysis.
Han J; Yu Y; Wu S; Wang Z; Zhang W; Zhao M; Yao Y; Hu Y; Wang W; Liu X; Yu W; Cheng J; Yu L; Bao Q; Zhang G; Yu X; Song R
J Int Med Res; 2020 Aug; 48(8):300060520930856. PubMed ID: 32865070
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Survivin Expression in Osteosarcoma Patients: A Meta-Analysis.
Liu Y; Teng Z; Wang Y; Gao P; Chen J
Med Sci Monit; 2015 Sep; 21():2877-85. PubMed ID: 26408642
[TBL] [Abstract][Full Text] [Related]
10. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
11. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
[TBL] [Abstract][Full Text] [Related]
14. Current Treatment Considerations for Osteosarcoma Metastatic at Presentation.
Tsukamoto S; Errani C; Angelini A; Mavrogenis AF
Orthopedics; 2020 Sep; 43(5):e345-e358. PubMed ID: 32745218
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.
Wunder JS; Gokgoz N; Parkes R; Bull SB; Eskandarian S; Davis AM; Beauchamp CP; Conrad EU; Grimer RJ; Healey JH; Malkin D; Mangham DC; Rock MJ; Bell RS; Andrulis IL
J Clin Oncol; 2005 Mar; 23(7):1483-90. PubMed ID: 15735124
[TBL] [Abstract][Full Text] [Related]
16. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
[TBL] [Abstract][Full Text] [Related]
17. Histologic Response and Toxicity following Interval-Compressed Four-Drug Therapy Given Preoperatively in Children and Young Adults with Osteosarcoma: A Retrospective Study.
Kang JM; Ju HY; Joo J; Sung JY; Park SY; Kim JH; Kang HG; Kwon M; Park M; Park HJ; Park BK
Oncology; 2020; 98(2):81-90. PubMed ID: 31509843
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.
Wittig JC; Bickels J; Priebat D; Jelinek J; Kellar-Graney K; Shmookler B; Malawer MM
Am Fam Physician; 2002 Mar; 65(6):1123-32. PubMed ID: 11925089
[TBL] [Abstract][Full Text] [Related]
19. Current treatment of osteosarcoma.
Ferguson WS; Goorin AM
Cancer Invest; 2001; 19(3):292-315. PubMed ID: 11338887
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
